XJPX
4323
Market cap281mUSD
Jul 10, Last price
1,783.00JPY
1D
-3.41%
1Q
-11.60%
Jan 2017
776.17%
IPO
1,059.67%
Name
Japan System Techniques Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Japan System Technique Co., Ltd. engages in the business of customized software development services. It operates through the following segments: DX & SI Business, Package Business, Medical Big Data Business, and Global Business. The DX & SI Business segment leverages its strengths as a completely independent business to provide a wide variety of information systems and services across a broad range of fields. The Package Business segment provides related environment creation and system development, with a focus on the development, sales and implementation consulting of in-house branded products. The Medical Big Data Business segment offers total services for medical insurance claims from automatic inspection of receipts and medical information data, analysis, and other related services. The Global Business segment provides development, sales, implementation consulting and system development for ERP and HRM products overseas. The company was founded by Takeaki Hirabayashi on March 26, 1973 and is headquartered in Osaka, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||